As NFκB signaling mediates activation of ISGs, we examined reverse-phase protein array (RPPA) data from the cancer cell line encyclopedia (CCLE)25 and found higher levels of activating serine 536 phosphorylation on p6526 in low NE-score SCLC lines (Fig. 2c). The gene discussed is NFKB1; the disease is cancer.